Aziyo Biologics Retained Earnings 2011-2026 | AZYO

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.

Possible uses include

reinvestment in development (R&D, equipment, marketing)
debt repayment
acquisition of other companies
creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Aziyo Biologics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-176 M	-230 M	-176 M	-138 M	-105 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-105 M	-230 M	-165 M

Quarterly Retained Earnings Aziyo Biologics

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-247 M	-243 M	-234 M	-221 M	-222 M	-194 M	-166 M	-157 M	-146 M	-138 M	-133 M	-123 M	-113 M	-105 M	-96 M	-87.7 M	-85.3 M	-80.3 M	-80.3 M	-80.3 M	-80.3 M	-56.9 M	-56.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-56.9 M	-247 M	-137 M

Retained Earnings of other stocks in the Medical devices industry

Issuer	Retained Earnings	Price	% 24h	Market Cap	Country
Aethlon Medical AEMD	-168 M	$ 2.24	0.9 %	$ 3.5 M	USA
Acutus Medical AFIB	-600 M	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	-15.7 M	-	3.58 %	$ 2.21 M	USA
AdaptHealth Corp. AHCO	-633 M	$ 10.47	0.19 %	$ 1.41 B	USA
GenMark Diagnostics, Inc. GNMK	-533 M	-	-	$ 1.77 B	USA
Alphatec Holdings ATEC	-1.42 B	$ 12.56	-3.75 %	$ 1.88 B	USA
Obalon Therapeutics, Inc. OBLN	-185 M	-	-5.86 %	$ 30.6 M	USA
Avinger AVGR	-421 M	-	-20.74 %	$ 369 K	USA
ClearPoint Neuro CLPT	-217 M	$ 9.61	-13.93 %	$ 272 M	USA
Cognyte Software Ltd. CGNT	-157 M	$ 8.37	0.12 %	$ 601 M	Israel
Butterfly Network BFLY	-802 M	$ 3.95	-7.49 %	$ 836 M	USA
Cytosorbents Corporation CTSO	-304 M	$ 0.65	-4.41 %	$ 35.4 M	USA
Cutera CUTR	-303 M	-	-10.19 %	$ 1.99 M	USA
BIOLASE BIOL	-317 M	-	-13.19 %	$ 166 K	USA
Conformis CFMS	-581 M	-	-	$ 16.4 M	USA
Boston Scientific Corporation BSX	5.57 B	$ 71.28	0.11 %	$ 106 B	USA
Apollo Endosurgery APEN	-337 M	-	-	$ 475 M	USA
EDAP TMS S.A. EDAP	-82.6 M	$ 3.92	-3.21 %	$ 146 M	France
CONMED Corporation CNMD	589 M	$ 36.71	-1.69 %	$ 1.14 B	USA
Establishment Labs Holdings ESTA	-496 M	$ 65.5	0.75 %	$ 1.94 B	Costa-rica
CryoLife, Inc. CRY	20 M	-	-4.14 %	$ 702 M	USA
Dynatronics Corporation DYNT	-40.5 M	-	14.99 %	$ 929 K	USA
Axonics Modulation Technologies AXNX	-374 M	-	-	$ 3.31 B	USA
Soliton, Inc. SOLY	-70.6 M	-	-1.42 %	$ 435 M	USA
GBS GBS	-62.5 M	-	-0.57 %	$ 7.12 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-56.2 M	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-119 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	-39.3 M	-	-	$ 462 M	USA
Neovasc NVCN	-395 M	-	-	$ 111 M	Canada
FONAR Corporation FONR	-33.6 M	$ 18.44	-0.05 %	$ 121 M	USA
Intersect ENT, Inc. XENT	-303 M	-	-	$ 955 M	USA
InMode Ltd. INMD	969 M	$ 13.45	-1.47 %	$ 869 M	Israel
Abbott Laboratories ABT	49.8 B	$ 108.49	-2.04 %	$ 189 B	USA
Delcath Systems DCTH	-529 M	$ 9.38	-3.7 %	$ 336 M	USA
Bio-Rad Laboratories BIO	7.42 B	$ 267.99	-0.55 %	$ 7.56 B	USA
Helius Medical Technologies HSDT	-160 M	$ 2.07	-4.61 %	$ 1.26 M	USA
Integra LifeSciences Holdings Corporation IART	940 M	$ 8.9	-2.2 %	$ 685 M	USA
IRIDEX Corporation IRIX	-79 M	$ 1.33	-	$ 21.5 M	USA
AxoGen AXGN	-307 M	$ 30.94	-5.53 %	$ 1.42 B	USA
Align Technology ALGN	2.48 B	$ 172.41	-2.11 %	$ 12.9 B	USA
Bruker Corporation BRKR	2.41 B	$ 34.03	0.86 %	$ 5.07 K	USA
BioSig Technologies BSGM	-255 M	-	37.08 %	$ 85.7 M	USA
Apyx Medical Corporation APYX	-89.1 M	$ 3.67	-1.87 %	$ 151 M	USA
OrthoPediatrics Corp. KIDS	-275 M	$ 16.66	-3.2 %	$ 391 M	USA
Second Sight Medical Products EYES	-122 M	-	-0.97 %	$ 54.4 M	USA
Accuray Incorporated ARAY	-519 M	$ 0.41	5.24 %	$ 42.1 M	USA
IRadimed Corporation IRMD	64.2 M	$ 99.67	-3.04 %	$ 1.27 B	USA